How large is the negative pressure wound therapy market, and what is its growth trajectory?
The negative pressure wound therapy market size has grown strongly in recent years. It will grow from $3.03 billion in 2024 to $3.19 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to an aging population, hospital-acquired infections, a rise in surgical procedures, healthcare infrastructure development, and reimbursement policies.
The negative pressure wound therapy market size is expected to see strong growth in the next few years. It will grow to $4.07 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to the prevalence of lifestyle-related diseases, home-based healthcare, global health crisis preparedness, patient preference for non-invasive treatments, value-based healthcare models, increasing incidence of chronic wounds. Major trends in the forecast period include technological innovations, telemedicine integration, personalized wound care, collaborations and partnerships, regulatory compliance, and standardization.
Get Your Free Sample of The Global Negative Pressure Wound Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5687&type=smp
What are the key forces behind the negative pressure wound therapy market’s growth in recent years?
The growing prevalence of diabetes is expected to propel the growth of the negative pressure wound therapy market. Diabetic foot ulceration (DFU) is the most common application area of negative pressure wound therapy. A diabetic person’s wounds are difficult to heal because people with uncontrolled diabetes may develop poor circulation, which results in less oxygenated circulation to the wound and the tissues do not heal as quickly. Thus, negative pressure wound therapy offers better graft take-up than conventional dressing for diabetic patients. For instance, in July 2023, the International Diabetes Federation (IDF), a Belgum-based non-profit organization, reported that 540 million people aged 20-79 were living with diabetes in 2022, with the number projected to rise to 643 million by 2030 and 783 million by 2045. Therefore, the growing prevalence of diabetes drives the negative pressure wound therapy market.
What are the major segments of the negative pressure wound therapy market?
The negative pressure wound therapy market covered in this report is segmented –
1) By Product: Conventional NPWT Devices, Single Use NPWT Devices
2) By Wound Type: Surgical And Traumatic Wounds, Ulcers, Burns
3) By End User: Hospitals, Homecare, Other End-Users
Subsegments:
1) By Conventional NPWT Devices: Portable NPWT Systems, Stationary NPWT Systems, Canister-Based NPWT Devices
2) By Single-Use NPWT Devices: Disposable NPWT Systems, Battery-Operated NPWT Devices, Compact NPWT Units
Order your report now for swift delivery
Which companies dominate the negative pressure wound therapy market?
Major companies operating in the negative pressure wound therapy market include Devon International Group, ConvaTec Group plc., DeRoyal Industries Inc., Smith & Nephew plc, Acelity L.P. Inc., Mölnlycke Health Care AB, ATMOS MedizinTechnik GmbH & Co. KG, Cardinal Health Inc., Talley Group Limited, Medela AG, Lohmann & Rauscher GmbH & Co. KG, Triage Meditech Pvt. Ltd., Carilex Medical GmbH, Shandong Weigao Xinsheng Medical Devices Co. Lt, Genadyne Biotechnologies Inc., B. Braun Melsungen AG, Cork Medical LLC, BSN medical GmbH, Investor AB, Olle Larsson Holding AG, PAUL HARTMANN Asia-Pacific Ltd., KCI Licensing Inc., Arjo USA Inc., 3M Company, MPM Medical Inc., Prospera Technologies Inc., Innovative Therapies Inc., Laboratoires URGO, 4L Health Co. Ltd, Pensar Medical LLC, Virchow Biotech Pvt. Ltd., Arobella Medical LLC, Spincare Inc., Ursapharm Arzneimittel GmbH
What are the top industry trends projected to impact the negative pressure wound therapy market?
The growing technological advancements are a key trend gaining popularity in the negative pressure wound therapy market. Major companies operating in the negative pressure wound therapy market are focusing on developing technological solutions for negative pressure wound therapy. For instance, in August 2022, 3M, a US-based multinational conglomerate company launched a new 3M Veraflo Cleanse Choice Complete Dressing Kit for negative pressure wound therapy with instillation and a software upgrade for the 3M V.A.C. Ulta Therapy Unit. The new offerings aim to simplify care delivery processes for clinicians and improve the experience for patients by making dressing changes easier, faster, and less painful. The software upgrade automates therapy initiation and includes helpful features, while the new dressing kit simplifies application and includes a gentler drape for patient comfort. These advancements are designed to enhance the efficiency and effectiveness of Veraflo Therapy in wound care.
Which geographic trends are shaping the negative pressure wound therapy market, and which region has the highest market share?
North America was the largest region in the negative pressure wound therapy market in 2024. Asia-Pacific is the fastest-growing region in the negative pressure wound therapy market share. The regions covered in the negative pressure wound therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, Africa.
What Does The Negative Pressure Wound Therapy Market Report 2025 Offer?
The negative pressure wound therapy market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Negative-pressure wound therapy (NPWT) is a therapeutic technique that uses a vacuum dressing to promote healing in acute or chronic wounds and enhances healing of second and third-degree burns.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5687
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
